Repeated injections in the same spot can cause lipodystrophy, the formation of hard or lumpy tissue that affects absorption
Made by Novo Nordisk, Rybelsus is the first oral GLP-1 prescription medication approved by the US Food and Drug Administration (FDA) to treat type 2 diabetes
There is evidence that when GLP-1 drugs are used responsibly alongside nutritional, activity and psychological support, they have a positive long-term impact on heart health, diabetes, breast & womb cancer and inflammatory diseases, beyond mere weight loss
Mitochondria begin relying more on fat oxidation (fat burning), which is metabolically efficient long-term but requires more oxygen and feels subjectively harder in the moment
GLP-1 weight loss products are designed to treat type 2 diabetes
Anticholinergic drugs, some blood pressure medications, and high-dose fiber supplements taken at the same time as injections may reduce bioavailability